Quarterly report pursuant to Section 13 or 15(d)

Acquisitions - Schedule of Intangible Assets Acquired (Details)

v3.19.3
Acquisitions - Schedule of Intangible Assets Acquired (Details) - USD ($)
 3 Months Ended 10 Months Ended
Jun. 30, 2018
Sep. 30, 2018
Jun. 30, 2019
Jun. 29, 2019
Feb. 16, 2018
Nov. 17, 2017
Avadel            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:         $ 18,291,000  
Intangible assets $ 1,838,000          
TRx            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:           $ 19,596,000
Intangible assets   $ 1,528,000        
PAI Sales & Marketing Agreement | TRx            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:           2,553,000
Intangible assets   219,000        
Karbinal | Acquired product marketing rights | Avadel            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:         6,200,000  
Intangible assets (21,000)          
AcipHex | Acquired product marketing rights | Avadel            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:         2,803,000  
Intangible assets 283,000          
Cefaclor | Acquired product marketing rights | Avadel            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:         7,611,000  
Intangible assets 1,320,000          
Flexichamber | Developed Technology Rights | Avadel            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:     $ 0 $ 1,400,000 1,677,000  
Intangible assets 546,000          
LiquiTime Process | In Process Research and Development | Avadel            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:         0  
Intangible assets $ (290,000)          
Metafolin | Acquired product marketing rights | TRx            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:           11,987,000
Intangible assets   1,522,000        
Millipred | Acquired product marketing rights | TRx            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:           5,056,000
Intangible assets   342,000        
Ulesfia | Acquired product marketing rights | TRx            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:           0
Intangible assets   $ (555,000)        
Previously Reported | Avadel            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:         16,453,000  
Previously Reported | TRx            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:           18,068,000
Previously Reported | PAI Sales & Marketing Agreement | TRx            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:           2,334,000
Previously Reported | Karbinal | Acquired product marketing rights | Avadel            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:         6,221,000  
Previously Reported | AcipHex | Acquired product marketing rights | Avadel            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:         2,520,000  
Previously Reported | Cefaclor | Acquired product marketing rights | Avadel            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:         6,291,000  
Previously Reported | Flexichamber | Developed Technology Rights | Avadel            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:         1,131,000  
Previously Reported | LiquiTime Process | In Process Research and Development | Avadel            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:         $ 290,000  
Previously Reported | Metafolin | Acquired product marketing rights | TRx            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:           10,465,000
Previously Reported | Millipred | Acquired product marketing rights | TRx            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:           4,714,000
Previously Reported | Ulesfia | Acquired product marketing rights | TRx            
Business Acquisition [Line Items]            
Identifiable Intangible Assets:           $ 555,000